Search results
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 1 hour agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Reuters via AOL· 26 minutes agoThe drug, an antibody-drug conjugate (ADC), was being studied in a trial sponsored by China-based...
AstraZeneca/Fibrogen’s Roxadustat FDA Review Further Delayed Following Unanticipated Advisory...
Clinical Trials Arena via Yahoo Finance· 7 hours agoFDA Delays Decision on AstraZeneca/Fibrogen’s Roxadustat for CKD Anemia On March 1, AstraZeneca and...
Cucumber recall update as FDA sets highest risk level
Newsweek· 1 day agoA range of recalled whole cucumbers have been designated a Class I risk level by the U.S. Food and...
Mifepristone is safe for now, but another challenge waits on the horizon
The Hill· 29 minutes agoOn Thursday, in Alliance for Hippocratic Medicine v. FDA, the Supreme Court unanimously dismissed a lawsuit intended to limit access to mifepristone, a drug commonly used ...
More people sent to hospital as mushroom-infused 'microdosing' chocolate faces ongoing FDA probe
Fox News via Yahoo News· 13 hours agoThe FDA recently announced that 10 consumers who ate Diamond Shruumz "microdosing" chocolate and...
AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval
Pharmaceutical Technology via Yahoo Finance· 2 hours agoAstraZeneca's Imfinzi (durvalumab), in combination with chemotherapy, has received approval from the...
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 6 hours agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
Pharmaceutical Technology via Yahoo Finance· 4 hours agoThe US Food and Drug Administration (FDA) has approved Amgen’s BLINCYTO (blinatumomab) for...
Tharimmune Announces Positive Type C Meeting with FDA for Phase 2 Program for TH104, its Lead...
The Joplin Globe· 53 minutes agoFood and Drug Administration (FDA) for its Phase 2 clinical trial with TH104, a proprietary transmucosal buccal film embedded with the approved, active compound nalmefene ...